Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
Status:
Active, not recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
Prospective, uncontrolled, investigator-initiated, phase II clinical study to explore the
activity of trabectedin in a population of patients aged ≥16 years with progressive, advanced
(locally advanced or metastatic)